Published April 1, 2020 | Version Accepted Version
Journal article Open

Adherence to and Retention in Medications for Opioid Use Disorder among Adolescents and Young Adults

  • 1. Yale University School of Public Health, Department of Social and Behavioral Sciences, New Haven, Connecticut
  • 2. Independent Consultant, New Orleans, Louisiana
  • 3. Yale University School of Medicine, Department of Psychiatry, Program for Recovery and Community Health, New Haven, Connecticut
  • 4. Harvey Cushing/John Hay Whitney Medical Library, Yale University, New Haven, Connecticut
  • 5. Yale University Center for Interdisciplinary Research on AIDS, New Haven, Connecticut

Description

Abstract The volatile opioid epidemic is associated with higher levels of opioid use disorder (OUD) and negative health outcomes in adolescents and young adults. Medications for opioid use disorder (MOUD) demonstrate the best evidence for treating OUD. Adherence to and retention in MOUD among adolescents and young adults, however, is incompletely understood. This systematic review examines the state of the literature regarding the association of age with adherence to and retention in MOUD using methadone, buprenorphine, or naltrexone among persons aged 10 to 24 along with related facilitators and barriers. The research team searched for all studies of MOUD that examined adherence, retention, or related concepts as an outcome variable where the sample included adolescents or young adults. Search criteria generated 10,229 records, which, after removing duplicates and conducting title/abstract screening, yielded 587 studies for full-text review. Ultimately, 52 articles met inclusion criteria for abstraction and 17 were selected for qualitative coding and analysis. This review found younger age to be consistently associated with shorter retention in the published literature, although the overall quality of included studies was low. Several factors at the individual, interpersonal, and institutional levels, such as concurrent substance use, MOUD adherence, family conflict, and MOUD dosage and flexibility, were seen as playing a role in MOUD retention among adolescents and young adults. This review highlights how MOUD providers can tailor treatment to increase retention of adolescents and young adults while pointing to the need for more research explaining MOUD adherence and retention disparities in this age group.

This is a pre-copyedited, author-produced PDF of an article accepted for publication in 'Epidemiologic Reviews' following peer review. The version of record [Viera, A., Bromberg, D.J., Whittaker, S., Refsland, B.M., Stanojlović, M., Nyhan, K., and Altice, F.L. (2020). Adherence to and Retention in Medications for Opioid Use Disorder among Adolescents and Young Adults. Epidemiologic Reviews.] is available online at: https://doi.org/10.1093/epirev/mxaa001.

Deposited by shareyourpaper.org and openaccessbutton.org. We've taken reasonable steps to ensure this content doesn't violate copyright. However, if you think it does you can request a takedown by emailing help@openaccessbutton.org.

Files

Files (219.7 kB)

Name Size Download all
md5:be0e3602b3e5f4c2d78160f41cef5630
219.7 kB Download